Stay updated on Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial page
- Check4 days agoChange DetectedThe footer’s site revision marker changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check11 days agoChange DetectedThe footer now identifies the ClinicalTrials.gov site revision as v3.7.1 instead of v3.7.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the previous study content with a generic error page and removing the surrounding navigation.SummaryDifference18%

- Check53 days agoChange DetectedThe page shows Revision: v3.6.6, replacing the previous Revision: v3.6.5, indicating a minor update to the entry.SummaryDifference0.1%

- Check74 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing Revision: v3.6.4, indicating a platform update. This change does not affect the study details or other visible content.SummaryDifference0.1%

- Check88 days agoChange DetectedRevision label was updated from v3.6.3 to v3.6.4, indicating a new build of the page. This update does not modify the study information or how the page functions.SummaryDifference0.1%

Stay in the know with updates to Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial page.